RT Journal Article
SR Electronic
T1 652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A743
OP A743
DO 10.1136/jitc-2023-SITC2023.0652
VO 11
IS Suppl 1
A1 Naing, Aung
A1 Mamdani, Hirva
A1 Barve, Minal
A1 Pelster, Meredith
A1 Haymaker, Cara
A1 Derbala, Mohamed
A1 Goon, Jack
A1 Darko, Samuel
A1 Murphy, Julie
A1 Gorelik, Lauren
A1 Bierly, Allison
A1 Ferrando-Martinez, Sara
A1 Lee, Byung Ha
A1 Yang, Se Hwan
A1 Lee, Siyoung
A1 Chaney, Marya
A1 Kim, Richard D
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A743.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.